CHOP Gene Therapy Experts Profiled in Philadelphia Magazine
May 12, 2021
CHOP researchers were interviewed as a part of a comprehensive article about cell and gene therapy in Philadelphia Magazine.
Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED) News
Your child will be cared for by a world-renowned team of experts in red cell disorders. We provide medical care, emotional counseling and much more. We make sure your child and every member of your family get the highest level of support.
CHOP Researchers Develop Potentially Safer, More Effective Gene Therapy Vector for Blood Disorders
Jan 29, 2021
CHOP researchers have developed a gene therapy vector for sickle cell disease and other blood disorder that is potentially superior to competitors.
CHOP Hematologist Hails Approval of Two New Drugs To Manage Sickle Cell Disease (SCD)
Nov 26, 2019
The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease.
Breakthrough New Therapies Approved for the Treatment of Sickle Cell Disease
Nov 26, 2019
The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.
New Studies Provide Important New Clues For Treating Red Blood Cell Disorders
Nov 13, 2019
Stefano Rivella, PhD, an expert in creating the next-generation lentiviral vectors for the cure of hemoglobinopathies including sickle cell disease (SCD), as well as a leader in the discovery of erythroid and iron disorders including beta-thalassemia, has led three new published studies that make significant contributions to the scientific body of literature regarding red blood cells, and how manipulating the production of red cells can lead to the development of new disease-modifying therapies.